Mass Spectrometry-Based Metabolomics Revealed Effects of Metronidazole on Giardia duodenalis
暂无分享,去创建一个
Phornpimon Tipthara | J. Tarning | O. Reamtong | S. Ampawong | Tipparat Thiangtrongjit | Supaluk Popruk | Amanee Abu | Suthasinee Sreesai | A. Abu
[1] S. Payungporn,et al. Gut bacteriome and metabolome of Ascaris lumbricoides in patients , 2022, Scientific Reports.
[2] M. Dea-Ayuela,et al. Flavonoids from Piper Species as Promising Antiprotozoal Agents against Giardia intestinalis: Structure-Activity Relationship and Drug-Likeness Studies , 2022, Pharmaceuticals.
[3] E. S. Coimbra,et al. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis , 2021, Medical Microbiology and Immunology.
[4] K. Hanevik,et al. Giardiasis treatment: an update with a focus on refractory disease , 2020, Current opinion in infectious diseases.
[5] R. Leurs,et al. Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi , 2020, Antimicrobial Agents and Chemotherapy.
[6] N. Komalamisra,et al. Efficacy of Ageratum conyzoides extracts against Giardia duodenalis trophozoites: an experimental study , 2020, BMC Complementary Medicine and Therapies.
[7] C. Sergi,et al. Giardiasis : An overview. , 2019, Recent patents on inflammation & allergy drug discovery.
[8] N. Chondrogianni,et al. Protein synthesis inhibition induces proteasome assembly and function. , 2019, Biochemical and biophysical research communications.
[9] Mohsen Arbabi,et al. Giardia lamblia infection: review of current diagnostic strategies , 2019, Gastroenterology and hepatology from bed to bench.
[10] B. Sarmento,et al. Metronidazole within phosphatidylcholine lipid membranes: New insights to improve the design of imidazole derivatives , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[11] Joachim Müller,et al. Physiological aspects of nitro drug resistance in Giardia lamblia , 2018, International journal for parasitology. Drugs and drug resistance.
[12] N. Luplertlop,et al. Featured Article: Immunomodulatory effect of hemozoin on pneumocyte apoptosis via CARD9 pathway, a possibly retarding pulmonary resolution , 2018, Experimental biology and medicine.
[13] D. Leitsch. A review on metronidazole: an old warhorse in antimicrobial chemotherapy , 2017, Parasitology.
[14] A. Bocedi,et al. Proteomic and functional analyses reveal pleiotropic action of the anti-tumoral compound NBDHEX in Giardia duodenalis , 2017, International journal for parasitology. Drugs and drug resistance.
[15] S. Svärd,et al. An up-date on Giardia and giardiasis. , 2016, Current opinion in microbiology.
[16] Patricia Kissinger,et al. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues , 2015, BMC Infectious Diseases.
[17] J. Ramírez,et al. Molecular diagnosis and genotype analysis of Giardia duodenalis in asymptomatic children from a rural area in central Colombia. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[18] V. Cama,et al. Infections by Intestinal Coccidia and Giardia duodenalis. , 2015, Clinics in laboratory medicine.
[19] E. Nohýnková,et al. The effect of metronidazole on the cell cycle and DNA in metronidazole-susceptible and -resistant Giardia cell lines. , 2014, Molecular and biochemical parasitology.
[20] L. Pucillo,et al. O2-Dependent Efficacy of Novel Piperidine- and Piperazine-Based Chalcones against the Human Parasite Giardia intestinalis , 2013, Antimicrobial Agents and Chemotherapy.
[21] M. Duchêne,et al. Nitroimidazole drugs vary in their mode of action in the human parasite Giardia lamblia. , 2012, International journal for parasitology. Drugs and drug resistance.
[22] H. Ke,et al. Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite. , 2011, Future medicinal chemistry.
[23] L. Eckmann,et al. Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. , 2011, The Journal of antimicrobial chemotherapy.
[24] K. Becker. Apicomplexan parasites: molecular approaches toward targeted drug development. , 2011 .
[25] H. Vial,et al. Lipids as drug targets for malaria therapy. , 2011 .
[26] H. Vial,et al. Glycerophospholipid acquisition in Plasmodium - a puzzling assembly of biosynthetic pathways. , 2010, International journal for parasitology.
[27] S. Svärd,et al. Behind the smile: cell biology and disease mechanisms of Giardia species , 2010, Nature Reviews Microbiology.
[28] C. Nord,et al. Metronidazole is still the drug of choice for treatment of anaerobic infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] M. an der Heiden,et al. Characteristics and risk factors for symptomatic Giardia lamblia infections in Germany , 2010, BMC public health.
[30] J. Aronson. Changing beta-blockers in heart failure: when is a class not a class? , 2008, The British journal of general practice : the journal of the Royal College of General Practitioners.
[31] I. Wilson,et al. Nitroimidazole Action in Entamoeba histolytica: A Central Role for Thioredoxin Reductase , 2007, PLoS biology.
[32] C. Hendriksz,et al. Prospective treatment in carnitine–acylcarnitine translocase deficiency , 2007, Journal of Inherited Metabolic Disease.
[33] S. Kunz,et al. The Trypanosoma brucei cAMP phosphodiesterases TbrPDEBl and TbrPDEB2: flagellar enzymes that are essential for parasite virulence , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] Ying Zhang,et al. HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..
[35] S. Phongpaichit,et al. The in vitro anti-giardial activity of extracts from plants that are used for self-medication by AIDS patients in southern Thailand , 2004, Parasitology Research.
[36] L. Eckmann. Mucosal defences against Giardia , 2003, Parasite immunology.
[37] C. Wójcik. Regulation of apoptosis by the ubiquitin and proteasome pathway , 2002, Journal of cellular and molecular medicine.
[38] R. D. Adam,et al. Biology of Giardia lamblia , 2001, Clinical Microbiology Reviews.
[39] P. Upcroft,et al. Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa , 2001, Clinical Microbiology Reviews.
[40] R. Dagan,et al. Giardia lamblia carriage in Israeli Bedouin infants: risk factors and consequences. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] L. Petrelli,et al. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. , 1996, European journal of pharmacology.
[42] D. S. Reiner,et al. Cell biology of the primitive eukaryote Giardia lamblia. , 1996, Annual review of microbiology.
[43] W. Colli,et al. Structural analysis of inositol phospholipids from Trypanosoma cruzi epimastigote forms. , 1995, The Biochemical journal.
[44] E. Kaneshiro,et al. Detection of ubiquinone in parasitic and free-living protozoa, including species devoid of mitochondria. , 1994, Molecular and biochemical parasitology.
[45] J. Tocher,et al. The interaction of reduced metronidazole with DNA bases and nucleosides. , 1992, International journal of radiation oncology, biology, physics.
[46] M. Müller,et al. Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities , 1983, Antimicrobial Agents and Chemotherapy.
[47] D. Keister. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[48] D. I. Edwards,et al. Effect of tinidazole, metronidazole and nitrofurazone on nucleic acid synthesis in Clostridium bifermentans. , 1976, The Journal of antimicrobial chemotherapy.
[49] R. Ings,et al. The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms. , 1974, Biochemical pharmacology.